Heidelberg, Germany

Wilfred Lubisch

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Gmbh & Co Kg. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wilfred Lubisch. Retrieved from https://idiyas.com/inventor/wilfred-lubisch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Spotlight on Inventor Wilfred Lubisch: Pioneer in Medicinal Chemistry

Introduction:

Wilfred Lubisch is a respected inventor in the field of medicinal chemistry, hailing from Heidelberg, Germany. With a keen focus on developing innovative pharmaceutical solutions, he has made significant contributions to the medical industry.

Latest Patents:

Wilfred Lubisch holds one patent for "Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands." This patent showcases his expertise in creating novel compounds for the prophylaxis and treatment of vasopressin-dependent and oxytocin-dependent diseases.

Career Highlights:

Currently employed at Abbott GmbH & Co. KG, Wilfred Lubisch has demonstrated a strong commitment to research and development in the pharmaceutical sector. His dedication to advancing medicinal products has led to the successful creation of groundbreaking solutions for complex medical conditions.

Collaborations:

Throughout his career, Wilfred Lubisch has collaborated with notable colleagues such as Herve Geneste and Thorsten K. Oost. Together, they have worked on various projects aimed at improving patient outcomes and enhancing the efficacy of pharmaceutical treatments.

Conclusion:

Inventor Wilfred Lubisch's pioneering work in medicinal chemistry has not only contributed to the growth of the pharmaceutical industry but has also positively impacted the lives of countless individuals. His innovative approach to drug discovery continues to inspire future generations of researchers and inventors in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…